Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q2-2020 Pharmacy & Infusion Services Update

Skip to the end of the Expertise Menu

Q2-2020 Pharmacy & Infusion Services Update

The pharmacy services market observed healthy deal activity across specialty, compounding, and E-Pharmacy management. While public health demands have restricted foot-traffic in the retail setting, pharmacy players are relying on recent investments in delivery systems and patient-centric technology to promote patient outcomes. This has positioned many stakeholders to succeed during the COVID-19 pandemic. While onboarding of new patients will remain artificially suppressed through the coming quarters, Provident expects an eventual uptick in patient volume as diagnostics of new patients catches up to real demand.

To print and download the full Pharmacy & Infusion Services Update report, please click below…

[holo_button icon=”” link=”/wp-content/uploads/2020/07/Q2-2020-Pharmacy-and-Infusion-Newsletter.pdf” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]


Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.